secwatch.observer — SEC 8-K summary
======================================

Issuer:     WINDTREE THERAPEUTICS INC /DE/ (WINT)
CIK:        0000946486
Form:       8-K
Filed at:   2024-04-19T23:59:59+00:00
Accession:  0001437749-24-012577
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 3.03, 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Windtree Therapeutics announces 1-for-18 reverse stock split effective April 19, 2024
--------------------------------------------------------------------------------

- Board set reverse split ratio at 1-for-18; effective 11:59 p.m. ET on April 19, 2024.
- Common stock to trade split-adjusted on Nasdaq under symbol WINT starting April 22, 2024; new CUSIP 97382D 501.
- No fractional shares issued; holders entitled to a fractional share will receive one whole share instead.
- Proportional adjustments to conversion prices of 10% senior convertible notes due 2025 and Series B convertible preferred, and to exercise prices of stock options and warrants.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/946486/000143774924012577/0001437749-24-012577-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/946486/000143774924012577/wint20240417_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-24-012577

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer